Patents by Inventor Nicole van der Weerden
Nicole van der Weerden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10568930Abstract: Agents and formulations and cells including plant extracts are useful in a method for controlling pathogen infestation in human and animal subjects. A method for inhibiting growth or infestation of a pathogen in or on a human or animal subject, includes contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and either: (i) a proteinase inhibitor; or (ii) a chemical pathogenicidic or pathogenostatic agent; in a combined amount effective to inhibit growth or infestation of the pathogen.Type: GrantFiled: April 24, 2015Date of Patent: February 25, 2020Assignee: Hexima LimitedInventors: Nicole Van Der Weerden, Marilyn Anne Anderson, Jennifer Payne
-
Publication number: 20190327965Abstract: Pathogen infection and infestation can be controlled in humans, animals and plants by contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and a non-defensin peptide. Pathogen contamination in environmental locales can also be controlled. The combination of the defensin and peptide are synergistic compared to the use of each alone at the same individual dose as used in the combination. The combinations can be presented in agents and natural and synthetic formulations and extracts.Type: ApplicationFiled: March 18, 2019Publication date: October 31, 2019Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
-
Patent number: 10357536Abstract: The protection of plants and human and non-human subjects from pathogens enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects. A method for protecting a subject from a disease associated with infection by a pathogen includes providing cells of said subject with a Class I defensin and a permeabilizing defensin or a precursor or a functional homolog, analog, derivative or variant thereof of either or both.Type: GrantFiled: March 23, 2018Date of Patent: July 23, 2019Assignee: Hexima LimitedInventors: Nicole Van Der Weerden, Marilyn Anne Anderson
-
Patent number: 10231450Abstract: Agents and natural and synthetic formulations and extracts are useful in control of pathogen infection and infestation in humans, animals and plants, as well as pathogen contamination in environmental locales. A method inhibits growth or infection or infestation of a pathogen, including contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and a non-defensin peptide, such as a cathelicidin peptide, a hairpin peptide, a hairpin peptide from which disulfide bridges have been removed, indolicidin, synthetic peptide CP-29, or a peptide derived from a cystatin. The combination of the defensin and peptide are synergistic compared to the use of each alone at the same individual dose as used in the combination.Type: GrantFiled: April 23, 2015Date of Patent: March 19, 2019Assignee: Hexima LimitedInventors: Nicole Van Der Weerden, Marilyn Anne Anderson
-
Patent number: 10174339Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.Type: GrantFiled: October 18, 2016Date of Patent: January 8, 2019Assignee: Hexima LimitedInventors: Nicole Van Der Weerden, Marilyn Anne Anderson
-
Publication number: 20180214512Abstract: The protection of plants and human and non-human subjects from pathogens enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects. A method for protecting a subject from a disease associated with infection by a pathogen includes providing cells of said subject with a Class I defensin and a permeabilizing defensin or a precursor or a functional homolog, analog, derivative or variant thereof of either or both.Type: ApplicationFiled: March 23, 2018Publication date: August 2, 2018Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
-
Patent number: 9943564Abstract: The present disclosure teaches the protection of plants and human and non-human subjects from pathogens. The present disclosure enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects.Type: GrantFiled: November 22, 2013Date of Patent: April 17, 2018Assignee: Hexima LimitedInventors: Nicole Van Der Weerden, Marilyn Anne Anderson
-
Patent number: 9848603Abstract: A system for reducing the incidence or severity of fungal infection of a plant, comprising a chemical fungicide component, which may be provided by foliar or root (soil or liquid nutrient) application, together with an antifungal plant defensin not in nature expressed in the plant being protected or expressed in lower amounts or in different tissues, provides synergistic improvement in protection against infection by a plant pathogenic fungus which is susceptible to the defensin and the fungicide. The fungicide can be a strobilurin or a triazole, and the defensin can be selected from a wide range of known defensins, for example, NaD1 and others, or it can be a chimeric defensin engineered for low toxicity to the plant. The defensin can be provided as a protein formulation, optionally together with the fungicide, or it can be provided by recombinant expression in the plant to be protected from fungal infection.Type: GrantFiled: May 12, 2015Date of Patent: December 26, 2017Assignee: Hexima LimitedInventors: Marilyn Anderson, Robyn Heath, James McKenna, Nicole Van Der Weerden
-
Publication number: 20170049102Abstract: Agents and natural and synthetic formulations and extracts are useful in control of pathogen infection and infestation in humans, animals and plants, as well as pathogen contamination in environmental locales. A method inhibits growth or infection or infestation of a pathogen, including contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and a non-defensin peptide, such as a cathelicidin peptide, a hairpin peptide, a hairpin peptide from which disulfide bridges have been removed, indolicidin, synthetic peptide CP-29, or a peptide derived from a cystatin. The combination of the defensin and peptide are synergistic compared to the use of each alone at the same individual dose as used in the combination.Type: ApplicationFiled: April 23, 2015Publication date: February 23, 2017Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
-
Publication number: 20170042966Abstract: Agents and formulations and cells including plant extracts are useful in a method for controlling pathogen infestation in human and animal subjects. A method for inhibiting growth or infestation of a pathogen in or on a human or animal subject, includes contacting the pathogen with an effective amount of a combination of a plant defensin or a functional natural or synthetic derivative or variant thereof and either: (i) a proteinase inhibitor; or (ii) a chemical pathogenicidic or pathogenostatic agent; in a combined amount effective to inhibit growth or infestation of the pathogen.Type: ApplicationFiled: April 24, 2015Publication date: February 16, 2017Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON, Jennifer PAYNE
-
Publication number: 20170029842Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.Type: ApplicationFiled: October 18, 2016Publication date: February 2, 2017Inventors: Nicole VAN DER WEERDEN, Marilyn Anne ANDERSON
-
Patent number: 9497908Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.Type: GrantFiled: February 7, 2012Date of Patent: November 22, 2016Assignee: HEXIMA LIMITEDInventors: Nicole Van Der Weerden, Marilyn Anne Anderson
-
Publication number: 20150283204Abstract: The present disclosure teaches the protection of plants and human and non-human subjects from pathogens. The present disclosure enables a multivalent approach to inhibiting pathogen infection in plant and human and non-human animal subjects and to ameliorate damage to susceptible subjects.Type: ApplicationFiled: November 22, 2013Publication date: October 8, 2015Applicant: Hexima LimitedInventors: Nicole Van Der Weerden, Marilyn Anne Anderson
-
Publication number: 20150237860Abstract: A system for reducing the incidence or severity of fungal infection of a plant, comprising a chemical fungicide component, which may be provided by foliar or root (soil or liquid nutrient) application, together with an antifungal plant defensin not in nature expressed in the plant being protected or expressed in lower amounts or in different tissues, provides synergistic improvement in protection against infection by a plant pathogenic fungus which is susceptible to the defensin and the fungicide. The fungicide can be a strobilurin or a triazole, and the defensin can be selected from a wide range of known defensins, for example, NaD1 and others, or it can be a chimeric defensin engineered for low toxicity to the plant. The defensin can be provided as a protein formulation, optionally together with the fungicide, or it can be provided by recombinant expression in the plant to be protected from fungal infection.Type: ApplicationFiled: May 12, 2015Publication date: August 27, 2015Inventors: Marilyn ANDERSON, Robyn HEATH, James MCKENNA, Nicole VAN DER WEERDEN
-
Publication number: 20140130209Abstract: This disclosure relates generally to the field of anti-pathogenic agents, including a modified defensin molecule with anti-pathogen activity. Genetically modified plants and their progeny or parts expressing or containing the modified defensin and anti-pathogen compositions for use in horticulture and agriculture and as animal and human medicaments are also provided.Type: ApplicationFiled: February 7, 2012Publication date: May 8, 2014Applicant: HEXIMA LIMITEDInventors: Nicole Van Der Weerden, Marily Anne Anderson
-
Publication number: 20090197809Abstract: A system for reducing the incidence or severity of fungal infection of a plant, comprising a chemical fungicide component, which may be provided by foliar or root (soil or liquid nutrient) application, together with an antifungal plant defensin not in nature expressed in the plant being protected or expressed in lower amounts or in different tissues, provides synergistic improvement in protection against infection by a plant pathogenic fungus which is susceptible to the defensin and the fungicide. The fungicide can be a strobilurin or a triazole, and the defensin can be selected from a wide range of known defensins, for example, NaD1 and others, or it can be a chimeric defensin engineered for low toxicity to the plant. The defensin can be provided as a protein formulation, optionally together with the fungicide, or it can be provided by recombinant expression in the plant to be protected from fungal infection.Type: ApplicationFiled: January 30, 2009Publication date: August 6, 2009Applicant: Hexima LimitedInventors: Marilyn Anderson, Robyn Heath, James McKenna, Nicole van der Weerden